Increased SKP2 and CKS1 Gene Expression Contributes to the Progression of Human Urothelial Carcinoma
Author:
Affiliation:
1. Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
2. Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference20 articles.
1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006
2. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years;Holmang;J Urol,1995
3. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27;Ganoth;Nat Cell Biol,2001
4. A CDK-independent function of mammalian Cks1: Targeting of SCF (Skp2) to the CDK inhibitor p27Kip1;Spruck;Mol Cell,2001
5. p27 destruction: Cks1 pulls the trigger;Bartek;Nat Cell Biol,2001
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1;Scientific Reports;2021-10-26
2. ABT-751 Induces Multiple Anticancer Effects in Urinary Bladder Urothelial Carcinoma-Derived Cells: Highlighting the Induction of Cytostasis through the Inhibition of SKP2 at Both Transcriptional and Post-Translational Levels;International Journal of Molecular Sciences;2021-01-19
3. PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer;Frontiers in Oncology;2020-10-07
4. CKS1B as Drug Resistance-Inducing Gene—A Potential Target to Improve Cancer Therapy;Frontiers in Oncology;2020-09-25
5. Aberrantly expressed PLOD 1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target;Molecular Oncology;2019-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3